Cargando…
Summary of COVID-19 Vaccine-Related Reports in the Vaccine Adverse Event Reporting System
Identification of the severe acute respiratory syndrome coronavirus 2 in humans toward the end of 2019 triggered a rapid, intensive effort to develop a vaccine. Among the first three COVID-19 vaccines granted emergency use authorization by the U. S. Food and Drug Administration (FDA) were two mRNA v...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809454/ https://www.ncbi.nlm.nih.gov/pubmed/35198503 http://dx.doi.org/10.4103/jrpp.jrpp_49_21 |